Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v2.3.0.15
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Oct. 01, 2011
Oct. 02, 2010
Operating activities    
Net income $ 4,780,001 $ 2,572,034
Adjustments to reconcile net income to net cash (used in) provided by continuing operating activities:    
Depreciation expense 2,289,789 2,004,721
Amortization of deferred charges 20,685 5,340
Deferred income taxes 62,072 (130,545)
Provision for losses on accounts receivable 246,293 114,754
Provision for losses on inventory 1,259,000 50,502
Gain on sale of property, plant and equipment (37,025) (46,223)
Cash value of life insurance (54,001) (66,163)
Environmental reserves (202,667) (169,392)
Issuance of treasury stock for director fees 78,704 67,478
Employee stock option and stock grant compensation 199,866 132,331
Changes in operating assets and liabilities:    
Accounts receivable (8,884,756) (8,266,279)
Inventories (11,706,393) (11,116,849)
Other assets and liabilities (112,967) 453,716
Accounts payable 3,436,697 710,715
Accrued expenses 1,875,991 7,262,451
Income taxes payable (154,970) (1,751,220)
Net cash used in operating activities (6,903,681) (8,172,629)
Investing activities    
Purchases of property, plant and equipment (1,985,046) (4,782,486)
Proceeds from sale of property, plant and equipment 49,301 56,832
Net cash used in investing activities (1,935,745) (4,725,654)
Financing activities    
Net borrowings from long-term debt 8,688,180 1,772,568
Dividends paid 0 (1,581,084)
Proceeds from exercised stock options 161,903 39,066
Net cash provided by (used in) financing activities 8,850,083 230,550
Increase (decrease) in cash and cash equivalents 10,657 (12,667,733)
Cash and cash equivalents at beginning of period 108,902 14,096,557
Cash and cash equivalents at end of period $ 119,559 $ 1,428,824